BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1696248)

  • 41. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
    Dubner SJ; Elencwajg BD; Palma S; Mendelzon R; Ramos A; Bertolasi CA
    Am Heart J; 1985 Mar; 109(3 Pt 1):523-8. PubMed ID: 3883728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of flecainide acetate in the treatment of premature ventricular contractions.
    Abitbol H; Califano JE; Abate C; Beilis P; Castellanos H
    Am Heart J; 1983 Feb; 105(2):227-30. PubMed ID: 6823803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes, arrhythmic burden and ambulatory monitoring of pediatric patients with left ventricular non-compaction and preserved left ventricular function.
    Czosek RJ; Spar DS; Khoury PR; Anderson JB; Wilmot I; Knilans TK; Jefferies JL
    Am J Cardiol; 2015 Apr; 115(7):962-6. PubMed ID: 25665759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mexiletine. Long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias.
    Kerin NZ; Aragon E; Marinescu G; Faitel K; Frumin H; Rubenfire M
    Arch Intern Med; 1990 Feb; 150(2):381-4. PubMed ID: 2302013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flecainide: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP; Tilley-Gray B
    Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Flecainide: a new class Ic antidysrhythmic.
    Smith GH
    Drug Intell Clin Pharm; 1985 Oct; 19(10):703-7. PubMed ID: 3902429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flecainide dose-response relations in stable ventricular arrhythmias.
    Woosley RL; Siddoway LA; Duff HJ; Roden DM
    Am J Cardiol; 1984 Feb; 53(5):59B-65B. PubMed ID: 6695819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term antiarrhythmic therapy with flecainide.
    Meinertz T; Zehender MK; Geibel A; Treese N; Hofmann T; Kasper W; Pop T
    Am J Cardiol; 1984 Jul; 54(1):91-6. PubMed ID: 6741844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.
    Hodges M; Haugland JM; Granrud G; Conard GJ; Asinger RW; Mikell FL; Krejci J
    Circulation; 1982 May; 65(5):879-85. PubMed ID: 7074749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short- and long-term experience with flecainide acetate in the management of refractory life-threatening ventricular arrhythmias.
    Lal R; Chapman PD; Naccarrelli GV; Troup PJ; Rinkenberger RL; Dougherty AH; Ruffy R
    J Am Coll Cardiol; 1985 Oct; 6(4):772-9. PubMed ID: 3928725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exercise-induced ventricular tachycardia as a manifestation of flecainide toxicity.
    Hoffmann A; Wenk M; Follath F
    Int J Cardiol; 1986 Jun; 11(3):353-5. PubMed ID: 3721634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of a digitalis drug on ventricular premature beats.
    Lown B; Graboys TB; Podrid PJ; Cohen BH; Stockman MB; Gaughan CE
    N Engl J Med; 1977 Feb; 296(6):301-6. PubMed ID: 63914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of oral digoxin on ventricular ectopy and its relation to left ventricular function.
    Gradman AH; Cunningham M; Harbison MA; Berger HJ; Zaret BL
    Am J Cardiol; 1983 Mar; 51(5):765-9. PubMed ID: 6338689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiarrhythmic therapy with flecainide in combination and comparison with propranolol.
    Stern H; Scheininger M; Theisen F; Theisen K
    Drugs; 1985; 29 Suppl 4():77-85. PubMed ID: 4006784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias.
    Facchini M; Bonazzi O; Priori SG; Varisco T; Zuanetti G; Schwartz PJ
    Eur Heart J; 1988 May; 9(5):462-70. PubMed ID: 3402461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction of ventricular arrhythmias by atenolol.
    Heng MK; Zimmer I
    Am Heart J; 1985 Jun; 109(6):1273-80. PubMed ID: 4003239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The response of paediatric arrhythmias to intravenous and oral flecainide.
    Wren C; Campbell RW
    Br Heart J; 1987 Feb; 57(2):171-5. PubMed ID: 3101724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A preliminary study on oral flecainide acetate in treating tachyarrhythmias].
    Li XY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Apr; 17(2):107-10. PubMed ID: 2477207
    [No Abstract]   [Full Text] [Related]  

  • 60. Frequent or complex ventricular ectopy in apparently healthy subjects: a clinical study of 25 cases.
    Kennedy HL; Underhill SJ
    Am J Cardiol; 1976 Aug; 38(2):141-8. PubMed ID: 952258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.